Adam Baer
1.4K posts

Adam Baer
@AdamBaer88
El Cant del Barça Lebe dein Leben, denn du Lebst nur einmal!
Bremen Katılım Temmuz 2015
544 Takip Edilen218 Takipçiler
Adam Baer retweetledi

@TimesFreePress Policy changes at the ownership and structure level can ripple through the system, affecting network design, pharmacy participation, and ultimately patient access.
English

Tennessee lawmakers overwhelmingly passed legislation banning a pharmacy from owning a pharmacy benefit manager, effectively targeting one of the largest health care conglomerates in the country. timesfreepress.com/news/2026/apr/…
English
Adam Baer retweetledi


@kpharmd12 Pharmacy only stores reflect system adaptation, but the underlying pressure still starts earlier in the chain with how drug prices are initially set by Big Pharma.
English

CVS unveils “pharmacy-only” store in Chicago.
“Each location will average less than 5,000 square feet, and will feature a full-service pharmacy with limited over-the-counter products available for purchase”
You just described what an independent pharmacy does.
This is not earth-breaking news.
Maybe if reimbursements from CVS Caremark weren’t dog-shit garbage, then more pharmacies like this wouldn’t have been forced to close in their communities.
Just some food for thought @CVSHealth @cvspharmacy, not like you all give a shit about what’s best for any given community.

English
Adam Baer retweetledi

@angrydadwi Independent pharmacies aren’t just retail points, they’re also where a lot of medication guidance happens. Losing them can widen the information gap for patients.
English

🚨 Your access to affordable medication is at risk.
Independent pharmacies are disappearing—and patients are paying the price.
The Pharmacists Fight Back Act is pushing for:
👉 Lower drug costs
👉 More transparency
👉 Patient choice
Take action now:
pharmacistsfightback.org
📣 Contact your legislators and demand change.
#FightBack #PatientAdvocacy #Healthcare
English
Adam Baer retweetledi

🚨🎖️| 𝐁𝐑𝐄𝐀𝐊𝐈𝐍𝐆: Marc Casado has decided to LEAVE Barcelona at the end of the season. [@Alfremartinezz] #fcblive 💣

English

@ladydatadoc @realdocspeaks PBMs are part of how drug benefits are managed, but a lot of the real cost pressure patients feel still comes from high-priced specialty drugs caused by drug manufacturers. That’s where affordability challenges are most visible.
English

Realistically we need PBMs; they are never going away.
…managing pharmaceutical use and its related cost is very complex; even though 83-87% of drugs are dispensed as generic the remaining ones are very costly and the main driver of costs (growing at 12-20 % a year) are specialty drugs for cancer immune rare diseases/conditions.
And today’s medicine and the pathway to recovery for most care is this formula
Pharmaceutical + genetics + diagnostic acumen + occasional intervention procedure
Meanwhile we are going thru a revolution in healthcare; just read about the kid in NYC we cured of sickle cell!
Unbelievable in reality in this case.
English

The cash price of office visits is too low to ensure. It is less than a trip to the grocery store.
You can get DPC for less than a month than cable or a cell phone.
Part D increases the amount we spend on drugs; it doesn't save us money.
Part D turns over our prescription drug costs to the three large PBMs, and don't forget about their offshore GPOs!
Deborah Hammond@ladydatadoc
Part B and Part D is more than 70% of the cost for Medicare. Unrealistic to think people can pay out of pocket for Part B. And the payments to hospitals for less complex are not that much higher than the same services done in office visits. Just between 15-20% in total which if the parity regulations are put into place POS 19 and 11 will be the same (hospitals not happy w this proposal which is likely to happen in next 2 yrs). Example office visit might be $150 in POS 11 and $180 in POS 19. Cost share (20%) for patient is higher for the hospital owned one. Which patients to file complaints about.
English
Adam Baer retweetledi

@og_stokes It’s easy to focus on rebate mechanics, but employers, PBMs, and insurers all have defined roles. The bigger picture is making sure patients don’t face gaps in care or high out of pocket costs driven largely by manufacturer set drug prices.
English

A law required drug rebates be passed back to employers.
So insurers built shell entities to keep the money.
PBMs like Express Scripts, Optum Rx, and CVS Caremark funneled money through GPO shells (Ascent, Emisar, Zinc) to keep it.
$100M+ per employee. Untraceable flows.
Audit: $45M taken from postal workers’ plan—despite “100% pass-through” contracts.
Now racketeering cases are surfacing and you can imagine how much money these insurers must be spending to avoid mainstream discovery.
English





















